Calcineurin B subunit acts as a potential agent for preventing cardiac ischemia/reperfusion injury

• DOI: 10.1007/s11010-012-1407-7
• Publication Date: 2012-08-26T23:46:18Z
• Authors: Junxia Guo; Shengquan Mi; Jing Li; Wei Liu; Yanxia Yin; Qun Wei
• Keywords: Male; 0303 health sciences; Cardiotonic Agents; Calcineurin; Apoptosis; Arrhythmias, Cardiac; Myocardial Reperfusion Injury; Recovery of Function; In Vitro Techniques; Myocardial Contraction; Rats; Up-Regulation; Rats, Sprague-Dawley; Mice; Protein Subunits; 03 medical and health sciences; Animals, Newborn; Proto-Oncogene Proteins c-bcl-2; Animals; Myocytes, Cardiac; Cells, Cultured

Calcineurin B subunit (CnB) is the regulatory subunit of calcineurin (Cn), a Ca(2+)/calmodulin-dependent serine/threonine protein phosphatase. It has been reported that mice deleting the CnB gene lose nearly all Cn activity and show poor tolerance to cardiac stress; CnB gene expression is downregulated in the hearts of rats that have suffered ischemia/reperfusion (I/R) injury. Therefore, we wonder whether injection of exogenous CnB protein can prevent the rats from suffering I/R injury. In cardiomyocytes, fluorogenic labeling shows that exogenous CnB quickly enters the cell. Pretreatment of cardiomyocytes with CnB reduces apoptosis in response to hypoxia/reoxygenation injury (an in vitro model mimicking ischemia/reperfusion injury), and CsA reverses this effect by inhibiting Cn activity. Furthermore, CnB upregulates Bcl-2 and Bcl-XL expression in the process of hypoxia/reoxygenation injury, which may contribute to protecting cardiomyocytes against apoptosis. In vivo experiments shows that pretreatment with CnB improves cardiac contractile function and reduces the frequency of arrhythmias induced by global I/R injury. These findings reveal a novel function for CnB protein in cardiac stress response and suggest a possible application of CnB in coronary disease therapy.